Displaying 101–110 of 125 news results
Jun 3, 2019
A discussion of strategies concerning the development of autosomal dominant disease therapies at the Translational Research Acceleration Program (TRAP) in November 2013.
May 9, 2019
Bipartisan Bill Will Stimulate Up to $1 Billion in New Funding for Blindness Research
Mar 28, 2019
The Foundation Fighting Blindness is pleased to provide an audio recording and full transcripts of the Insights Forum, our quarterly conference call providing updates to the inherited retinal disease community. The call took place on March 22, 2019.
Mar 28, 2019
The Foundation announces several staffing changes with a focus on new strategies to increase awareness and engagement with the community.
Mar 7, 2019
Age-related macular degeneration (AMD) is the leading cause of blindness for people over 50 years of age in developed countries.
Oct 18, 2018
More than two decades ago, the Foundation Fighting Blindness (FFB) began funding RPE65 gene therapy research that led in late 2017 to LUXTURNA™, the first FDA-approved gene therapy for the eye or an inherited condition. Ultimately, the Foundation provided more than $10 million in funding for the groundbreaking effort.
Aug 28, 2018
The Foundation Fighting Blindness (FFB), the world’s leading private funding source for inherited retinal disease research, announced major awards in two areas: promising research projects in retinal diseases and career development for clinical researchers.
Jul 19, 2018
Bill Introduced in U.S. House Would Speed Up Cures for Blindness
Jul 17, 2018
Four research and development leaders share the latest details of their groundbreaking work in therapies for retinal degenerative diseases.
Jul 16, 2018
Dr. Kelley brings more than 25 years of experience in developing, identifying, and advancing life science technologies to this leadership role at FFB